TP53 and breast cancer: Inactivation of p53 in these patients was associated with reduced miR-30a expression and an associated decrease in miR-30a-mediated suppression of ZEB2 expression, thereby leading to enhanced breast cancer cell plasticity, migration, and metastasis [6].